Year None20232022202120202019201820172014 Nov 09, 2023 PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights Oct 12, 2023 PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation Oct 11, 2023 PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar Sep 20, 2023 PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Aug 09, 2023 PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights Jun 06, 2023 PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference May 10, 2023 PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights Mar 01, 2023 PMV Pharmaceuticals Reports Full Year 2022 Financial Results and Corporate Highlights Feb 28, 2023 PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March
